It's #NewMemberMonday! #AthensBioscience produces and tests purified native proteins and custom protein solutions across microgram-to-kilogram scales to support reproducible scientific research. @CGT_Global sources and isolates human biospecimens, specialized blood products and primary cells from healthy and diseased donors to accelerate drug discovery and clinical trials. #ElenaeTherapeutics combines AI drug design with targeted delivery strategies to develop RNA medicines for internal programs and partners. #HokanBio manages operations and long-term preservation infrastructure for natural history specimen collections, rescuing and warehousing at-risk biological samples to support environmental research. #MoktraBio develops targeted therapies that remove proteins that cause inflammation. #RASIRC converts liquids into reactive vapors for semiconductor and adjacent markets, enabling atomic-scale film growth at low temperatures within high-aspect-ratio structures.
2026 Catalyst Awardee Guosong Hong, Ph.D., of @Stanford made the world's first live transparent mice. Read his story: https://t.co/Ylv1l9W4s9 #BiocomCatalystAwards
Mentor registration for the 2027 cohort of @BiocomInstitute Life Science Career Fellowship is closing soon. California life science professionals at the managerial level or above can still secure a spot to guide emerging talent, sharpen their leadership skills and connect with regional peers dedicated to strengthening the life science workforce. With a flexible 15-hour hybrid commitment from January through June, mentors help fellows build career readiness — in the 2026 cohort, 95% of mentors agreed their fellows left fully prepared to enter the industry.
Don’t miss the opportunity to shape the next generation of life science leaders.
Sign up today: https://t.co/cUy1lP9XzA
Don’t miss Biocom's Bay Area Member Appreciation Holiday Party & Catalyst Award Ceremony on December 2. Enjoy festive refreshments, connect with fellow life science professionals and help us celebrate the outstanding individuals advancing human health. Learn more: https://t.co/BmiB7ld2EY
This week in Bay Area life sciences: #AdjuviaTherapeutics initiates a Phase 1 clinical trial of ATI-105 for the treatment of Friedreich’s ataxia. @Coherus_Bio presents compelling interim clinical data for tagmokitug in the treatment of esophageal cancer and outlines the therapy's development path. @novotechCRO offers an on-demand webinar exploring how strategic market selection and regulatory planning across the Asia-Pacific region can support global oncology drug development. Subscribe to receive the next newsletter in your inbox: https://t.co/IwjhL2qh3V
This week in San Diego life sciences: @DCNDiagnostics acquires BioSouthTech to expand its biospecimen collection network and improve access to diverse patient populations for drug and diagnostic research. @dexcom launches its "A Letter to Diabetes" campaign to collect stories from the global diabetes patient community. @VivoSimSolana and @chemveda collaborate to advance AI-designed drug candidates toward human testing. Subscribe to receive the next newsletter in your inbox: https://t.co/A2C8LXsy4y
Is there such a thing as engaging patients too early?
For life science companies, the focus is often on advancing the science, securing funding and reaching the next development milestone. So where does patient advocacy fit when a technology or therapy is still in its earliest stages?
Patient advocacy organizations can help companies understand unmet needs, inform research priorities and identify challenges that might otherwise be overlooked.
Biocom’s Patient Advocacy Initiative brings industry and patient communities together earlier and more effectively.
Join us for a virtual conversation with industry leaders and patient advocates about the opportunities and practical considerations of engaging patient communities throughout development.
December 1 | 11 a.m. PST | Virtual
Register https://t.co/HYxy63OZsm
#PatientAdvocacy #RareDisease #LifeSciences
2026 Biocom Catalyst Award winner Evan Feinberg of @genesismolai uses AI and physics-based simulation to advance drug discovery for challenging targets. Read his story: https://t.co/S1EejyBi6t #BiocomCatalystAwards
Congratulations to Biocom member Pictor on being named Proteomics Company of the Year in the 2026 BioTech Breakthrough Awards! The recognition highlights advances in its targeted proteomics platform, research and collaborations.
Learn more: https://t.co/VkMSSZDsC7
🚨 Attention life science innovators: only 1 day remaining to apply to present at our Global Partnering & Investor Conference. Don't miss this opportunity to showcase your latest innovations and gain additional exposure to over 600 potential investors and strategic partners in attendance. Apply to present at #BiocomGPIC by tomorrow, November 13: https://t.co/nTE0kS76HF
Biocom member @TaylorTalk (Taylor Design) is partnering with @UCSF to modernize labs at its Children’s Research Center, creating flexible, collaborative spaces that advance pediatric biomedical research while preserving the building’s historic character. Learn more: https://t.co/4xFybAcOCx
Biocom’s Medical Device & Diagnostics Committee regularly convenes leaders from across the medtech industry to explore how instrumentation, spatial biology and computational tools intersect to solve complex clinical challenges. By facilitating cross-disciplinary collaboration, Biocom helps our member community navigate the technical and regulatory changes shaping modern healthcare delivery.
The committee’s upcoming session will explore next-generation spatial biology and AI-enabled workflows on November 17 at 4:30 p.m. in San Diego.
Register: https://t.co/We9vpOoyoO
Meet 2026 Catalyst Awardee Christopher Farina, CEO of Abcentra. He’s targeting a root cause of heart attacks that cholesterol and blood pressure numbers can miss: inflamed arteries. Read more: https://t.co/2Qrzz2Bzz9 #BiocomCatalystAwards
The right introduction can change everything. Through Investor & Partner Days, Pitch Studio, Venture Hub and our partnership with Octane, Biocom connects medtech innovators with capital, partners and resources.
Explore membership: https://t.co/QNTm6DLy4r
#MedTech
It's #NewMemberMonday! #6SeeTherapeutics develops small-molecule therapies designed to protect and regenerate retinal ganglion cells, aiming to preserve and restore vision in patients with glaucoma and other optic neuropathies. #AugmentBiologics engineers biologics with its AI-driven GlycoTemplating platform to precisely control glycosylation and improve drug properties. #GridNorthSciences connects machine learning with experimental biophysics, pairing predictive models with targeted wet-lab experiments to accelerate development while reducing costs and material use. @my_helix provides clinical genomic testing and population health programs, and connects health systems with life science companies for research through the Helix Research Network. @MessinaGroupInc provides AI strategy and execution consulting for private equity firms and their portfolio companies to improve performance in line with their investment approaches. @PBSBiotech designs Vertical-Wheel® bioreactors that keep cells uniformly suspended with low-shear mixing, helping developers scale cell culture from process development to commercial production.
2026 Biocom Catalyst Award winner David de Vries, CEO of Tr1X, is advancing cell therapies for autoimmune and inflammatory diseases. Read his story: https://t.co/I8lNTklytj #BiocomCatalystAwards
Final savings for the Finance & Accounting for Bioscience West conference ends soon. Register by Friday, November 13 to save $200 on your pass.
Biocom member Informa will host its inaugural event December 7–8 at the Hilton La Jolla Torrey Pines. The forum will bring together bioscience CFOs, controllers and senior finance leaders to tackle shifting board expectations, capital allocation strategies and commercial launch readiness. Attendees will also explore how finance teams are leveraging AI and enterprise readiness planning (ERP) tools to improve forecasting accuracy and maintain audit readiness. View the full program: https://t.co/AmaL2hQkwa
Secure your registration before rates increase November 13.
Register: https://t.co/8P2UZxX93j
This week in Bay Area life sciences: #Corcept reports positive Phase 2 BELLA trial results for lifyorli in combination with nab-paclitaxel and bevacizumab for the treatment of platinum-resistant ovarian cancer. @FrontierMeds presents promising anti-tumor activity from Phase 1/2 PROSPER trial data for FMC-376 in the treatment of KRAS G12C-mutant non-small cell lung cancer. @IdeayaB27412 presents updated Phase 1 results demonstrating promising antitumor activity of IDE849 in relapsed small cell lung cancer and neuroendocrine carcinomas. #MTNRefrigeration shares preventive maintenance strategies to reduce refrigeration failures, downtime and batch losses in lyophilization processes. Subscribe to receive the next newsletter in your inbox: https://t.co/IwjhL2qh3V
2026 Biocom Catalyst Award winner Kevin Caldwell, co-founder and CEO of Ossium Health, is advancing stem cell products for patients with hematological diseases. Read his story: https://t.co/GhRDh0m7SB #BiocomCatalystAwards
Biocom actively connects innovators, clinicians and developers across the medtech industry to share practical insights, address integration hurdles and translate emerging technologies into real-world patient outcomes. Bringing members together around these shared challenges helps keep the medical technology sector collaborative, resilient and focused on meaningful clinical impact.
Interested in learning more? Biocom’s Medical Device & Diagnostics Committee will convene November 17 in San Diego to explore spatial biology and AI-driven workflows.
Register: https://t.co/kQgjdpmGJx